Symposium - European Medical Journal

Continue

Symposiums

Interventional Cardiology
9 Mins
31 May 2022

Contemporary Techniques to Treat Coronary Calcification

Calcific lesions, if not adequately pre-dilated, can prevent the successful expansion of a stent during percutaneous coronary intervention…
Hepatology
11 Mins
26 Apr 2022

The Impact of Paediatric Cholestatic Liver Disease: Diagnosis, Management, and Treatment Considerations

Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.
Oncology
13 Mins
12 Apr 2022

Clinical Implications of Emerging Metastatic Breast Cancer Data from ESMO 2021: Interviews with Two Key Opinion Leaders

Around 15–20% of breast cancers are characterised by amplification or overexpression of human epidermal growth factor receptor 2 (HER2)…
Hematology
10 Mins
22 Mar 2022

Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy

The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…
EMJ Oncology 10 [Supplement 6] 2022 Feature Image
Oncology
13 Mins
21 Mar 2022

Multidisciplinary Team Approach in Cancer Care: A Review of the Latest Advancements Featured at ESMO 2021

A collaborative approach from healthcare professionals is necessary for the management of patients with cancer to diagnose and treat…
Hematology
13 Mins
18 Mar 2022

The Future of Gene Therapy for Haemophilia A and B: Innovative Treatment Management Strategies, Perspectives, and Updated Trial Results

Monogenic diseases such as haemophilia A and B are inherited conditions arising from mutations in a single gene. One defective gene leads…
Nephrology
11 Mins
17 Mar 2022

Improving Outcomes for Haemodialysis Patients: Sizing Up the Problem – Interviews with Two Key Opinion Leaders

Despite recent developments in renal medicine, mortality rates remain high in patients receiving long-term haemodialysis (HD) due to…
EMJ Oncology 10 [Supplement 5] 2022 Feature Image
Oncology
8 Mins
7 Mar 2022

Implementation of MET Molecular Testing in the Clinic: Latest Evidence for Mesenchymal–Epithelial Transition Inhibitors in Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with many genomic mutations. Furthermore, comprehensive genomic…
We’ve noticed you’re accessing
from North/South America.